Compared to human insulin, IG has a slower onset but a significantly longer duration of action, contributing to its once-daily dosing and flatter pharmacokinetic profile [5], which helps improve postprandial blood glucose control and reduce nighttime hypoglycemia [6]. This evidence concerns the gene INS and Hypoglycemia.